Left ventricular hypertrophy

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Left ventricular hypertrophy is defined as left ventricular mass index > 118 g/m2 in men and > 104 g/m2 in women.[1]

Diagnosis

Electrocardiogram

Criteria

Various electrocardiographic criteria exist: Sokolow-Lyon index, Cornell voltage index, Cornell product, Gubner, and Romhilt-Estes score.[2] Sokolow-Lyon index

  • SV1+RV5>3.5 mV

or

  • V6>3.5 mV

Cornell voltage index

  • Males: RaVL+SV3>2.8 mV;
  • Females: RaVL+SV3>2.0 mV

Cornell product

  • Males: (SV3+RaVL)xQRS duration 2440 ms or more
  • Females: (SV3+(RaVL+8 mV))xQRS duration>2440 ms

Gubner criteria

  • RI+SII 25 mV or more

Romhilt-Estes score greater than 4 or 5 points:

  • Evidence of excessive voltage (any one of the following) - 3 points
    • largest R or S wave in limb leads 20 mV or more
    • S wave in V1
    • V2 30 mV or more
    • R wave in V5
    • V6 30 mV or more
  • Evidence of LV strain - 3 points (only 1 point if taking digitalis)
    • ST-T segment vector shifted opposite to QRS vector
  • Evidence of left atrial involvement - 3 points
    • terminal negativity of P wave in V1 1 mm or more with duration 0.04 s or more
  • Evidence of left axis deviation - 2 points
    • left axis –30° or less
  • Prolonged QRS duration - 1 point (0.09 s)
  • Intrinsicoid deflection - 1 point
    • intrinsicoid deflection (interval between start of QRS complex and peak of the R wave) in V5 or V6 0.05 s or more

Sensitivity and specificity

A systematic review found that the accuracy of the electrocardiographic indices and criteria for diagnosing left ventricular hypertrophy is:[2]

Treatment

Adrenergic beta-antagonists may be less effective according to meta-analyses[3][4] of randomized controlled trials such as LIFE[5] and others[6].

See also

References

  1. Molloy TJ, Okin PM, Devereux RB, Kligfield P (1992). "Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product". J. Am. Coll. Cardiol. 20 (5): 1180–6. PMID 1401620[e]
  2. 2.0 2.1 Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM (2007). "Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review". BMJ 335 (7622): 711. DOI:10.1136/bmj.39276.636354.AE. PMID 17726091. Research Blogging.
  3. Fagard RH, Celis H, Thijs L, Wouters S (2009). "Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.". Hypertension 54 (5): 1084-91. DOI:10.1161/HYPERTENSIONAHA.109.136655. PMID 19770405. Research Blogging.
  4. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE (2003). "A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.". Am J Med 115 (1): 41-6. PMID 12867233[e]
  5. Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G et al. (2003). "Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.". Ann Intern Med 139 (3): 169-77. PMID 12899584[e]
  6. Schulman SP, Weiss JL, Becker LC, Gottlieb SO, Woodruff KM, Weisfeldt ML et al. (1990). "The effects of antihypertensive therapy on left ventricular mass in elderly patients.". N Engl J Med 322 (19): 1350-6. DOI:10.1056/NEJM199005103221904. PMID 2139175. Research Blogging.